Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist
β Scribed by Parameswaran, R; Yu, M; Lim, M; Groffen, J; Heisterkamp, N
- Book ID
- 109887500
- Publisher
- Nature Publishing Group
- Year
- 2011
- Tongue
- English
- Weight
- 667 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
I t is clear that asparaginase will have to be combined with other drugs if it is to significantly affect survival of patients with ALL, in spite of the 50% remissions achieved, since these remissions are of such short duration. We have investigated the combination of asparaginase with the glutamine
## Abstract Intensive chemotherapy in patients with leukemia produces immunosuppression. The level of immunocompetence correlates with prognosis. The immunological function of 29 children with acute lymphoblastic leukemia (ALL) in complete remission and on 2 different maintenance therapies was eval
We report a case of a fatal toxic encephalomyelopathy in a 12-year-old girl due to prophylactic intrathecal injection of methotrexate and cytosine arabinoside, with a characteristic progressive symptomatology leading to death after 28 days. The location and type of neuropathological changes support